Entero Therapeutics 10K 2021 Annual report | ENTO Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: accessing, adaptively, adjournment, adrulipase, afflicted, Air, Alpha, anemia, ATM, autoimmune, azathioprine, baby, bacteria, Balchem, BCPC, BDSI, Biden, BioDelivery, biopsy, Black, bleeding, bloody, Boca, Boston, Bowdoin, broker, budesonide, Budget, calm, candidacy, cap, card, cardiorenal, Carolina, cascade, cavity, CD, cellular, Chancery, Charlotte, CINC, CinCor, clerical, Coelho, Cognex, colon, commonly, compensatory, complaint, concentrated, concert, confined, contest, CPA, cum, CUSIP, DC, deep, DGCL, disability, discomforting, disincentivizing, disorder, disqualification, Diversey, doctrine, dramatically, driven, durable, duty, dysregulated, Entyvio, Excellence, EyeGate, farther, fever, float, formatted, forum, fullest, fundamental, furniture, FW, FWB, FWBI, geopolitical, greatest, haul, hereditary, hereunder, HHS, Holy, IBMEC, ID, immunopathology, Importantly, India, inexpensive, inflamed, inflation, inline, innermost, instability, installment, intermittent, invasion, invasive, ISSUER, judgement, Kiora, KPRX, labor, laude, leaving, macroeconomic, main, Mayo, mesalamine, methotrexate, MFN, microbial, microgranule, mild, military, MINE, mission, mitochondria, mixture, moderate, modestly, molnupiravir, mucosal, muscle, NaN, newer, occupation, ophthalmic, opportunistically, OTC, overcoming, PASSPORT, patchier, pathogenic, PAXLOVIDTM, payout, penny, people, phosphorylation, pilot, Pink, postponement, prednisone, Prefunded, pro, proceeding, promptly, quorum, rata, Raton, rebate, recalculating, receptor, rectum, remediation, remission, renamed, representation, reservoir, RESEVOIR, restore, retroactively, Ridgeback, Road, Romano, Sarah, Score, Sealed, sigmoid, sigmoidoscopy, SoundBite, sparing, Stelara, steroid, stop, stringent, subgroup, suddenly, suggest, sulfasalazine, summa, surgical, swab, TechTarget, tenure, Terry, threatening, Tianjin, ticker, Tofacitinib, trait, transported, Treasurer, UC, Ukraine, umbrella, unconverted, undergo, undesignated, unexpensed, unlisted, UNRESOLVED, untouched, upsized, Ustekinumab, vacancy, VP, wall, Washington, Women, Xeljanz, Yamato, York, young

Removed: ABS, accreted, affiliated, Agricultural, Agronomique, attractive, AZRX, bacterial, build, Centre, chosen, claimed, coefficient, Colonial, consumed, credited, curtail, depreciable, diligent, discovered, dispute, encountered, ensuing, Enzymology, faster, field, Floor, Foundation, fourth, fundraising, gastroenterology, Helicobacter, Institut, IPO, JIST, Lake, lending, light, lung, Maged, modeling, nucleosidase, occurring, participated, peptic, physiology, pledge, prevail, pylori, Recherche, repay, revised, Salt, Shenouda, spend, strong, Tel, TRANSFERT, ulcer, Utah, validated, Vern

Entero Therapeutics (ENTO) 10-K2021 FY Annual report

Content analysis